ClinicalTrials.Veeva

Menu
B

Bogan Sleep Consultants, LLC | Columbia, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TAK-861
Pitolisant
FT218
TAK-925
Mazindol
JZP-258
Serdexmethylphenidate
BTD-001
SUVN-G3031
High-Sodium Oxybate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

17 of 43 total trials

A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia

The primary objective of this study is to assess the long-term safety and effectiveness of pitolisant in patients with idiopathic hypersomnia (IH) wh...

Active, not recruiting
Idiopathic Hypersomnia
Excessive Daytime Sleepiness
Drug: Pitolisant

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling
Narcolepsy Type 1
Drug: TAK-861

The primary purpose of this study is to evaluate the efficacy of single oral doses of E2086 compared to placebo in the treatment of excessive daytime...

Enrolling
Narcolepsy Type 1 (NT1)
Drug: Active Comparator Placebo
Drug: E2086 Placebo

This study will assess the safety and efficacy of JZP258 (XYWAV) on sleepiness, polysomnography, and functional outcomes in patients with idiopathic...

Enrolling
Idiopathic Hypersomnia
Narcolepsy
Drug: JZP258 (XYWAV)

Researchers are looking for a better way to treat women who have sleep disturbances associated with menopause.Menopause is part of a natural aging pr...

Active, not recruiting
Sleep Disturbances Associated With Menopause
Other: Placebo
Drug: Elinzanetant

The aim of this study is to quantify the change in blood pressure when participants with narcolepsy treated with high-sodium oxybate are transitioned...

Enrolling
Narcolepsy
Drug: JZP258

This study assesses the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to...

Enrolling
Insomnia
Drug: Daridorexant 10 mg
Drug: Daridorexant 25 mg

To evaluate the safety and effectiveness of the Automatic Expiratory Positive Airway Pressure (Auto-EPAP) feature versus manual expiratory positive a...

Active, not recruiting
Neuromuscular Diseases (NMD)
Obesity Hypoventilation Syndrome (OHS)
Device: Non-Invasive Ventilation

The objective of this study is to assess the efficacy of the eXciteOSA device amongst a sample of patients with mild OSA. The study is a multi-center...

Active, not recruiting
Sleep Apnea, Obstructive
Device: eXciteOSA

The solution offered by the Genio System to treat OSA patients with CCC using bilateral HGNS has a favorable risk-benefit ratio, as demonstrated by e...

Enrolling
Sleep Apnea, Obstructive
Device: Genio System

This is a double-blind, placebo-controlled, randomized withdrawal, multicenter study of the efficacy and safety of FT218 with an open-label safety ex...

Enrolling
Idiopathic Hypersomnia
Other: Placebo
Drug: FT218

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Enrolling
Asthma
Drug: Placebo
Drug: Dupilumab

The goal of this clinical trial is to learn about INS018_055 in adults with Idiopathic Pulmonary Fibrosis (IPF).The primary objective is to evaluate...

Enrolling
Idiopathic Pulmonary Fibrosis (IPF)
Drug: Placebo
Drug: INS018_055

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of MK-6552 in participants with Narco...

Enrolling
Narcolepsy
Drug: Placebo
Drug: MK-6552

Primary Objective:Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab SAR440340

The objective of this study is to determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive S...

Active, not recruiting
Sleep Apnea, Obstructive
Apnea, Sleep
Device: aerSleep II

Multi-center, open-label, prospective, randomized clinical trial of the aura6000(R) System for the reduction of apnea and hypopneas in adult patients...

Active, not recruiting
Hypopnea, Sleep
Apnea, Obstructive Sleep
Device: Hypoglossal Nerve Stimulation

Trial sponsors

Takeda logo
Jazz Pharmaceuticals logo
H
N
Apnimed logo
A
M
N
Sanofi logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems